| Name | Title | Contact Details |
|---|---|---|
Keith Olivia |
General Counsel and Vice President of Corporate Affairs | Profile |
Rogan Nunn |
General Counsel and Secretary | Profile |
Syner-G BioPharma Group is the premier solution provider of Chemistry, Manufacturing, and Controls (CMC) services for the life sciences industry. The company`s approach is based on CMC 360™, a fully integrated suite of CMC solutions that encompasses pharmaceutical development, regulatory affairs, and quality/cGxP compliance. The entire Syner-G organization is built around the premise of guiding small molecule, biologics, cell and gene therapy, and medical device innovators through the CMC process.
Ameridose is a Westborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Please select your location. United States International
NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington`s disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been “undruggable.” for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase`s pipeline includes
Iconix Biosciences is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.